Journal of Capital Medical University ›› 2008, Vol. 29 ›› Issue (2): 153-157.

• 基础研究 • Previous Articles     Next Articles

TRPC3 mediated Inhibition of MPP+ Neurotoxicity in MN9D Cells

Zhang Lei1, Wang Junfeng2, Ge Ruiliang3, Wang Xiaomin1   

  1. 1. Department of Physiology, Capital Medical University;2. Institute of Neuroscience, Chinese Academy of Sciences;3. Eastern Hepatobiliary Surgery Hospital, the Second Military Medical University
  • Received:2007-12-15 Revised:1900-01-01 Online:2008-04-24 Published:2008-04-24

Abstract: Objective To study the effect of transient receptor potential-canonical channel(TRPC) on MPP+-induced MN9D cell damage. Methods The MN9D cell damage model was induced by treating MN9D cells with different concentrations(62.5, 125, 250, 500, 1 000 μmol/L) of MPP+ for 24 h and with 500 μmol/L MPP+ for different time course(3, 6, 12, 24, 36 hours). The mRNA expression of the members of TRPC subfamily was investigated by RT-PCR and the protein levels of TRPCs by Western blot in MN9D cells. MTT was performed to detect TRPC3-mediated inhibition of MPP+ neurotoxicity in MN9D cells transfected by TRPC3-GFP and GFP adenovirus. Results 500 μmol/L MPP+ specifically reduced the protein levels of TRPC3 in MN9D cells and overexpression of TRPC3 protected MN9D cells from MPP+ neurotoxicity. Conclusion Degradation of TRPC3 induced by MPP+ was probably involved in pathogenesis of Parkinson's disease(PD) and this study maybe provide a new target to prevent and treat PD.

Key words: Parkinson's disease, MPP+, TRPC, neuroprotective effect

CLC Number: